Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Compared with anti-dsDNA-negative patients, anti-dsDNA-positive patients had significantly lower levels of C3, C4, the CD4+/CD8+ ratio, 25(OH)D, and PNI, together with a higher prevalence of renal involvement (all P < 0.05).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
According to anti-dsDNA titers, patients were further stratified into low-titer and high-titer groups.
Source: Abstract.
This single-center, hospital-based cross-sectional study was conducted at Hebei General Hospital (Shijiazhuang, China) between December 2023 and December 2024.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Combined assessment of 25(OH)D, CD4+/CD8+ ratio, and prognostic nutritional index for anti-dsDNA-based stratification in systemic lupus erythematosus
Cross-sectional study · Frontiers in Immunology · 2026
Original publication title
Combined assessment of 25(OH)D, CD4+/CD8+ ratio, and prognostic nutritional index for anti-dsDNA-based stratification in systemic lupus erythematosus
Copyright © 2026 Yang, Meng, Ding and Tie.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease in which anti-double-stranded DNA (anti-dsDNA) antibodies are closely associated with disease activity and organ involvement. However, the relationships of 25-hydroxyvitamin D [25(OH)D], CD4+/CD8+ ratio, and prognostic nutritional index (PNI) with anti-dsDNA antibody status and titer stratification remain incompletely understood.
Source: BackgroundAbstract: What methods does the paper describe?
A total of 126 patients with SLE were enrolled and classified into an anti-dsDNA-negative group and an anti-dsDNA-positive group. According to anti-dsDNA titers, patients were further stratified into low-titer and high-titer groups. Clinical characteristics and laboratory parameters, including 25(OH)D, CD4+/CD8+ ratio, and PNI, were compared among groups. Receiver operating characteristic curve analysis was performed to evaluate the discriminatory performance of 25(OH)D, CD4+/CD8+ ratio, PNI, and their combined model.
Source: MethodsAbstract: Results
Compared with anti-dsDNA-negative patients, anti-dsDNA-positive patients had significantly lower levels of C3, C4, the CD4+/CD8+ ratio, 25(OH)D, and PNI, together with a higher prevalence of renal involvement (all P < 0.05). Significant differences in 25(OH)D, the CD4+/CD8+ ratio, and PNI were also observed across the anti-dsDNA-negative, low-positive, and high-positive groups. In ROC analysis, 25(OH)D showed the highest AUC among the individual biomarkers for anti-dsDNA serostatus, whereas the combined assessment achieved the highest overall AUC.
For stratifying low-positive from high-positive anti-dsDNA titers, the combined assessment showed better discriminatory performance than PNI and C3.
Source: ResultsAbstract: Conclusions
Combined assessment of 25(OH)D, the CD4+/CD8+ ratio, and PNI may provide complementary value for anti-dsDNA-based stratification in SLE. Its performance was comparable to C3 for anti-dsDNA serostatus and superior to C3 for stratifying low-from high-positive anti-dsDNA titers. These findings should be considered exploratory and require validation in external cohorts.
Source: ConclusionsAuthors’ abstract
Background
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease in which anti-double-stranded DNA (anti-dsDNA) antibodies are closely associated with disease activity and organ involvement. However, the relationships of 25-hydroxyvitamin D [25(OH)D], CD4+/CD8+ ratio, and prognostic nutritional index (PNI) with anti-dsDNA antibody status and titer stratification remain incompletely understood.
Methods
A total of 126 patients with SLE were enrolled and classified into an anti-dsDNA-negative group and an anti-dsDNA-positive group. According to anti-dsDNA titers, patients were further stratified into low-titer and high-titer groups. Clinical characteristics and laboratory parameters, including 25(OH)D, CD4+/CD8+ ratio, and PNI, were compared among groups. Receiver operating characteristic curve analysis was performed to evaluate the discriminatory performance of 25(OH)D, CD4+/CD8+ ratio, PNI, and their combined model.
Results
Compared with anti-dsDNA-negative patients, anti-dsDNA-positive patients had significantly lower levels of C3, C4, the CD4+/CD8+ ratio, 25(OH)D, and PNI, together with a higher prevalence of renal involvement (all P < 0.05). Significant differences in 25(OH)D, the CD4+/CD8+ ratio, and PNI were also observed across the anti-dsDNA-negative, low-positive, and high-positive groups. In ROC analysis, 25(OH)D showed the highest AUC among the individual biomarkers for anti-dsDNA serostatus, whereas the combined assessment achieved the highest overall AUC.
For stratifying low-positive from high-positive anti-dsDNA titers, the combined assessment showed better discriminatory performance than PNI and C3.
Conclusions
Combined assessment of 25(OH)D, the CD4+/CD8+ ratio, and PNI may provide complementary value for anti-dsDNA-based stratification in SLE. Its performance was comparable to C3 for anti-dsDNA serostatus and superior to C3 for stratifying low-from high-positive anti-dsDNA titers. These findings should be considered exploratory and require validation in external cohorts.
Publication and source details
Original title: Combined assessment of 25(OH)D, CD4+/CD8+ ratio, and prognostic nutritional index for anti-dsDNA-based stratification in systemic lupus erythematosus
Chaoju Yang; Juntao Meng; Nan Ding; Yanqing Tie
Frontiers in Immunology · 2026
* Correspondence: Chaoju Yang, ycj040082@126.comCopyright © 2026 Yang, Meng, Ding and Tie.2026Yang, Meng, Ding and Tiehttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. Medical Science Research Project of Hebei (20240258).Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:18:22.380365+00:00
DOI: 10.3389/fimmu.2026.1841620 · PMC13167970